Disappearance of spironolactone-induced gynecomastia with triamteren.
Yamamoto
S
S
Department of Internal Medicine, Kawasaki Medical School, Kurashiki.
D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D013148:Spironolactone / Q000009:adverse effects*; D014223:Triamterene / Q000627:therapeutic use*
D004232:Diuretics; D013148:Spironolactone; D014223:Triamterene